Agoracom Blog Home

Author Archive

« Older Entries
Newer Entries »

Avicanna $AVCN.ca Advances its Supply Chain Business with Commercial Exports of #CBG And #CBD into the United States and Germany as well as Industrial Scale #THC Quota Granted by the Colombian Authorities $KHRN.ca $TRUL.ca $VFF.ca

Posted by AGORACOM-JC at 8:17 AM on Monday, August 24th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • The export of the CBG isolates into the United States is part of the first known industrial cultivation, extraction, and purification of cannabigerol (“CBG”) in Colombia, validating the Company’s early mover advantage in proprietary genetics, extraction, and high margin input materials.
  • The commercial THC cultivation quota for 11,587 psychoactive plants will be used for commercial production of THC derivatives for exports.
  • The group of exports into the United States were also piloted as a part of a global tracking system through StrainSecure™, a brand of TruTrace Technologies.

TORONTO, Aug. 24, 2020 – Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces that through its majority owned subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH“), the company has completed exports of CBG and CBD isolates into the United States, CBD isolate into Germany and the commencement of a pilot tracking system for the export of its active pharmaceutical ingredient (“API“) products in partnership with TruTrace Technologies Inc. (“TruTrace“) (CSE: TTT) (OTCQB: TTTSF). The Company is also pleased to announce that the Colombian Ministry of Justice and Law has granted SMGH a commercial and industrial cultivation quota for 12,264 THC plants by.

The export and sale of the commercial lot of isolated CBG into the United States was completed in parallel with commercial export of isolated CBD into the United States, as well as a pilot export for R&D purposes of CBD into Germany. The cultivation, extraction and purification of these cannabinoids including the rare cannabinoid, CBG, were all completed through Avicanna’s vertical integration at SMGH and validate the company’s innovation and leadership in natural rare cannabinoid production. The products are part of the Aureus™ product portfolio that now includes feminized seeds and advanced formulations as well as CBD, CBG and THC API products.

“This is another massive accomplishment for our team in Colombia as we enter the largest market in the world for non-psychoactive cannabinoids with our proprietary CBG offering. As the cannabinoid-derived products sector continues to evolve, our Aureus branded portfolio continues to advance in order to cater to the needs of our cosmetics and pharmaceutical partners, which require an innovative, credible, thoroughly-tested, organic, sustainable and economical source of input materials. Additionally, with the support of TruTrace, the Aureus products will be provided with traceability and trackability all the way back to the seed through a secured blockchain system.” – Aras Azadian, Chief Executive Officer of Avicanna.

The Colombian Ministry of Justice and Law granted SMGH a supplementary cultivation quota to cultivate 12,264 psychoactive cannabis plants. 11,587 plants will be destined to produce dry flower which will then be used to manufacture psychoactive derivatives for commercial production for export. The remaining 677 plants will be utilized for psychoactive derivatives for the purposes of research and development and pilot production of Avicanna’s RHO Phyto™ branded products in Colombia.

Lucas Nosiglia, President of Avicanna LATAM commented: “This achievement took years of characterization, evaluation and planning which will finally allow Avicanna to produce our THC products and export THC derivatives to our international partners. As one of the only companies permitted to produce THC commercially for the global market, we can focus on less competitive and high margin products.”

To the knowledge of the Company, it carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates.

About StrainSecure™ by TruTrace

Designed specifically by TruTrace for the cannabis industry, StrainSecure™ is a fully integrated software platform, secured on blockchain which aggregates and authenticates all testing and quality assurance data on products and verifies the quality of each batch and lot in distribution. Furthermore, this deployment will mark the first utilization by TruTrace of the OrionOne™ global freight and logistics solution in the cannabis sector thereby providing dynamic visibility of verified Aureus products through the entire international shipping process.

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

  • Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
  • RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of SMGH to continue to complete exports of CBD and CBG isolates to the United States and Germany, SMGH’s ability to continue selling CBD and CBG isolates in the United States and Germany, SMGH’s ability to make use of the supplementary cultivation quota granted by the Colombian Ministry of Justice and Law, the ability of the Company to produce THC products using API produced by SMGH, and the ability of SMGH to export THC derivatives internationally. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Tags: , , , ,
Posted in Avicanna Inc., Featured | Comments Off on Avicanna $AVCN.ca Advances its Supply Chain Business with Commercial Exports of #CBG And #CBD into the United States and Germany as well as Industrial Scale #THC Quota Granted by the Colombian Authorities $KHRN.ca $TRUL.ca $VFF.ca

University of Pittsburgh Joseph M. Katz Graduate School of Business Selects ImagineAR $IP.ca $IPNFF as Partner in New MBA Course $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:19 AM on Monday, August 24th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Announced the Joseph M. Katz Graduate School of Business at the University of Pittsburgh is unveiling a new and exciting business disruption series course called, “Augmented and Virtual Reality (AR/VR) for Brands and Strategy.”
  • The course, in partnership with ImagineAR will be taught by Vanitha Swaminathan, Thomas Marshall Professor of Marketing. “Augmented and Virtual Reality for Brands and Strategy” will be initially available for MBA and MS students and eventually to undergraduate students at the College of Business Administration

VANCOUVER, BC and ERIE, PA, Aug. 24, 2020 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, retailers and brands to create their own instant mobile phone AR campaigns,  is pleased to announce the Joseph M. Katz Graduate School of Business at the University of Pittsburgh is unveiling a new and exciting business disruption series course called, “Augmented and Virtual Reality (AR/VR) for Brands and Strategy.”

The course, in partnership with ImagineAR will be taught by Vanitha Swaminathan, Thomas Marshall Professor of Marketing. “Augmented and Virtual Reality for Brands and Strategy” will be initially available for MBA and MS students and eventually to undergraduate students at the College of Business Administration. The entirety of the course will be taught in an online format.  U.S. News & World Report has ranked the Katz Graduate School of Business 39th in its 2021 ranking of the Best Business Schools in the United States.

During the span of the course, students will work in teams to identify how to apply augmented and virtual reality to a real business or company and to design a branding campaign. To conclude the course, students will present a 10-minute video showcasing their ideas.

“We’re thrilled to introduce the new series of business disruption courses,” said Sara Moeller, Associate Dean for Graduate Programs. “Augmented and Virtual Reality for Brands and Strategy, the inaugural course, is the first step in many new and exciting game-changing courses to come.”

AR/VR technologies have the potential to have a transformational role in how students learn, how managers make decisions and how consumers interact with products and branded experiences. Every business today is required to have an augmented reality strategy in order to unlock creative potential inherent in various touchpoints and user interfaces. 

“The offering of this course is extremely unique and timely,” said Swaminathan. “The current health crisis has required marketers to be even more creative in how to engage fans and customers. Augmented and virtual reality tools will provide new, creative ways of engaging with customers during this challenging period of social distancing.”

Alen Paul Silverrstieen, CEO & President of Imagine AR stated, “The adoption of the AR/VR course by the esteemed Joseph M. Katz Graduate School of Business is a real testament to ImagineAR.  The school has identified ImagineAR as an industry leader and AR as an enormous opportunity for brands to engage customers during these times where traditional methods would not suffice. I look forward to working with Professor Swaminathan on this revolutionary course work.”

The course will tie into a new case competition, Katz Augmented Reality Case Competition (ARCC), co-sponsored by the Center for Branding, Katz Marketing Club, Katz Technology Club, and ImagineAR. Katz graduate students will compete in teams of four to showcase their futuristic and creative ideas for how products and brands can become more innovative in the future. The Katz ARCC will provide an important way for students to gain exposure to AR/VR technologies and will challenge them to think through the various ways in which it can improve the brand experience.

To learn more about the Augmented and Virtual Reality for Brands and Strategy course, click this link.

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO
(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if ImagineAR Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR Inc. management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws. 

SOURCE ImagineAR

Tags: , , , , , , ,
Posted in Imagine AR | Comments Off on University of Pittsburgh Joseph M. Katz Graduate School of Business Selects ImagineAR $IP.ca $IPNFF as Partner in New MBA Course $SEV.ca $VST.ca $YDX.ca $NTAR.ca

St-Georges Eco-Mining $SX $SX.ca $SXOOF Beyond The AGM

Posted by AGORACOM-JC at 10:59 AM on Sunday, August 23rd, 2020

Beyond The AGM – St-George Eco-Mining, Segment 1 – Iceland

St-Georges Eco-Mining President and CEO, Vilhjalmur T. Vilhjalmsson and Dr Helen Salmon, one of the most knowledgeable academics that has specialised in Iceland Geology, discuss the state of mineral exploration in Iceland. *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A


Beyond The AGM – St-George Eco-Mining, Segment 2 – Lithium Processing Tech

St-Georges Eco-Mining President and CEO, Vilhjalmur T. Vilhjalmsson and Enrico Di Cesare, President and CEO of St-Georges Metallurgy (A subsidiary of SX specialised in R&D) discuss the Company’s Lithium Processing Technology *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A

Beyond The AGM – St-George Eco-Mining, Segment 3 – Canadian Resource Assets

Frank Dumas, COO & Director of St-Georges Eco-Mining, discusses the status of the Company’s Canadian exploration assets, including Julie and Manicouagan. *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A

—-

Beyond The AGM – St-George Eco-Mining, Segment 4 – Borealis

Frank Dumas, COO & Director of St-Georges Eco-Mining, discusses the status of Borealis, a Distributed and Decentralised Digital Derivative marketplace that is currently 100% owned by St-Georges and is located in Iceland. *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A

Beyond The AGM – St-George Eco-Mining, Segment 5 – Management Discussion

St-Georges Eco-Mining President and CEO, Vilhjalmur T. Vilhjalmsson and Frank Dumas, COO & Director of St-Georges Eco-Mining, discuss the overall status of the Company, it’s recovery from August 2018 and bright future looking forward. *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A

Tags: , , , , , , ,
Posted in All Recent Posts, St Georges Eco-Mining Technologies | Comments Off on St-Georges Eco-Mining $SX $SX.ca $SXOOF Beyond The AGM

Kings of The North Redux – St-Georges Eco-Mining $SX $SX.ca $SXOOF

Posted by AGORACOM-JC at 4:35 PM on Friday, August 21st, 2020
  • Announced that the Company has entered into a conditional binding agreement with BWA Group Plc of London to acquire all the outstanding shares of King of the North (KOTN), sold by St-Georges to BWA in September 2019
  • At the time of the transaction in 2019, St-Georges held 50.18% of KOTN
  • The proposed transaction with BWA and subsequently with the third-party arm-length other holders of the BWA securities will make St-Georges 100% owners of KOTN, that will be, once again, a wholly-owned subsidiary

Montreal – August 21, 2020 – St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE:85G1) announces that the Company has entered into a conditional binding agreement with BWA Group Plc of London to acquire all the outstanding shares of King of the North (KOTN), sold by St-Georges to BWA in September 2019.

At the time of the transaction in 2019, St-Georges held 50.18% of KOTN. The proposed transaction with BWA and subsequently with the third-party arm-length other holders of the BWA securities will make St-Georges 100% owners of KOTN, that will be, once again, a wholly-owned subsidiary.

KOTN was acquired from St-Georges and other related parties by BWA in October 2019 for a consideration of GBP4.66 million. Unfortunately, primarily arising from the impact of the COVID-19 restrictions, it has proved impossible to manage and effectively develop the investment in KOTN from the UK.

As a result, it has been agreed between the parties that St-Georges and the related parties to the original transaction will acquire the BWA’s 100 percent interest in KOTN by means of the cancellation of unconverted elements of the Convertible Unsecured Loan Notes issued as the original purchase consideration, amounting to a total of GBP4.3 million, of which GBP2,281,580 is coming from St-Georges. In addition, St-Georges will issue 1,500,000 common shares in favor of BWA. These shares will be subject to a standard 4 months regulatory hold. After closing the transaction, St-Georges is expected to retain its equity interest in BWA, amounting to approximately 21%.

The transaction is conditional to St-Georges and BWA’s ability to enter into a separate agreement with the related third parties that were part of the 2019 transaction.

The parties expect this transaction will be completed by August 31, 2020. Further information will be disclosed in the coming weeks.

Vilhjalmur Thor Vilhjalmsson, President and CEO of St-Georges, commented, “(…) It is unfortunate that BWA Group has been restricted in its efforts to develop these assets due to the impact of the pandemic on their operations. (…) We wish them all the best in the new direction they are taking, and we will be a supportive shareholder in their future successes (…) we will review the strategy and work program of these assets and divulge our intentions in a follow-up press release in the coming days(…).“

The Company expects to disseminate a press release pertaining to its surface work campaign on the Iceland Thor Gold Project before common share transactions resume on the CSE.

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur T. Vilhjalmsson”

VILHJALMUR THOR VILHJALMSSON


President & CEO

About St-Georges Eco-Mining Corp.

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry. The Company controls all the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & the Manicouagan Palladium Project on Quebec’s North Shore. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Tags: , , , , , , ,
Posted in St Georges Eco-Mining Technologies | Comments Off on Kings of The North Redux – St-Georges Eco-Mining $SX $SX.ca $SXOOF

#Apple $AAPL quietly acquired Israel’s #Camerai, formerly #Tipit, a specialist in #AR and camera tech SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 9:12 AM on Friday, August 21st, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Apple quietly acquired Israel’s Camerai, formerly Tipit, a specialist in AR and camera tech

  • Apple is well known for picking up smaller startups on the hush-hush to augment its business, and today news leaked out about the latest of these… nearly two years after the fact
  • Sometime between 2018 and 2019, the iPhone giant reportedly acquired and shut down Camerai, an augmented reality and computer vision company based out of Israel, which used to be called Tipit.
  • Calcalist said that the startup sold for several tens of millions of dollars.
  • From being founded in 2015, Camerai had raised around $5 million — including a $2.5 million round in 2017 and another unreported $2.5 million in 2018 — with investors including the Atooro Fund and another called the SKO Fund.

By: Ingrid Lunden

Apple is well known for picking up smaller startups on the hush-hush to augment its business, and today news leaked out about the latest of these… nearly two years after the fact. Sometime between 2018 and 2019, the iPhone giant reportedly acquired and shut down Camerai, an augmented reality and computer vision company based out of Israel, which used to be called Tipit.

The news was first reported earlier today by Israeli newspaper Calcalist, and we have reached out to ask Apple directly about it. In the meantime, Jonathan (Yehonatan) Rimon, who had been Camerai’s CEO and co-founded the company with Moty Kosharovsky, Erez Tal and Aaron Wetzler, declined to comment one way or the other on the report when we contacted him directly about it. A separate source confirmed the story to us. We’ll update as we learn more.

Calcalist said that the startup sold for several tens of millions of dollars. From being founded in 2015, Camerai had raised around $5 million — including a $2.5 million round in 2017 and another unreported $2.5 million in 2018 — with investors including the Atooro Fund and another called the SKO Fund.

It seems that the acquisition came on the heels of multiple approaches from a number of companies at a time when AR was arguably at a peak of hype and many big tech companies wanted a piece of the action. (Recall that 2018 was the year when Magic Leap raised nearly $1 billion in a single round of funding.) Back in 2018, we heard rumors that those approaching and looking at the startup included Apple, Samsung and Alibaba.

The Calcalist report said that Camerai employees joined Apple’s computer vision team, and that the company’s technology has been incorporated into Apple products already. It’s not clear specifically where and when, but recall that both iOS 13 and iOS 14 have featured big software updates to the camera.

Camerai had built an SDK and specifically a range of software-based AR tools to help edit and use camera-made images in more sophisticated ways,

Its tech included the ability to detect different objects in the picture, and outline them with precision to alter them cosmetically; the ability to outline and apply filters across the whole image; a “skeleton tracking” neural network API that could detect and draw body joints in real time overlaid on a picture of a human; and its own version of selective focus for enhanced portrait modes (remember this was 2018 and this was not standard on phones at the time). Camerai’s site is shut down, but here are some screenshots of how it all looked, pulled from the Internet Archive:

Camerai’s acquisition underscores a couple of interesting, and ongoing, trends.

The first of these is in the development of smartphone technology, particularly around cameras. Some of the more interesting innovations in smartphone camera technology have come not out of improvements in hardware, but software, where the application of breakthroughs in artificial intelligence can mean that an existing combination of sensor, lens and on-phone and cloud processors produce a better and more technically dynamic picture than before.

At a time when smartphone replacement cycles have really slowed down and we are seeing also slower innovation on hardware, bolting on talent and tech created outside the phone companies is one way to gain a competitive edge.

(Separately, I wonder if making cutting-edge technology software-based also means that there could be scope in the future for paid updates to older phone models, which could mean more incremental revenues from consumers that don’t want to invest incompletely new devices.)

The second trend that this deal underscores is how Israel remains fertile ground for bigger companies on the hunt to pick up and bolt on technology, and that the secretive approach is likely to remain for some time to come.

“In Israel there are over 350 global corporate companies, from 30 countries, who search for local innovation. Some of them like Apple, MS, Google, even have local R&D [operations],” said Avihai Michaeli, a Tel Aviv-based senior investment banker and startup advisor. “Those global companies look mainly for tech which could serve as its competitive edge. It is not the first time that an acquired startup is asked not to publish it was acquired, nor talk about it.”

Other acquisitions that Apple has made in Israel have included camera module maker LinX, semiconductor startup Anobit and 3D sensor company PrimeSense.

We’ll update this post as we learn more.

Source: https://techcrunch.com/2020/08/20/report-apple-quietly-acquired-israels-camerai-formerly-tipit-a-specialist-in-ar-and-camera-tech/

Tags: , , , , , , , , ,
Posted in All Recent Posts, Imagine AR | Comments Off on #Apple $AAPL quietly acquired Israel’s #Camerai, formerly #Tipit, a specialist in #AR and camera tech SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

betterU $BTRU.ca Provides Business Update $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 8:29 AM on Friday, August 21st, 2020
  • Launch of betterU’s Europe SaaS B2B platform
  • Relaunch of India SaaS platform as a result of 1,272% increase in transactions for 2020
  • Extraordinary $60,000+ profit from sale of certain claim rights

OTTAWA, ON / August 21, 2020 / betterU Education Corp. (TSXV:BTRU)(FRA:5OGA) (the “Company” or “betterU”) is pleased to provide the following update on its business.

2020 year-to-date the Company has seen a substantial increase in interest from companies and governments from North America, Europe, Africa as well as India. Over the last couple months, betterU has completed multiple proposals that if completed would result in the company’s profitability within 2020.

To effectively access some of the global opportunities, betterU has adapted its platform to support global markets and is now in the process of launching its European SaaS platform. The platform is expected to launch before the end of August 2020. As part of betterU’s growth strategy in Europe, the Company is also in the process of completing the set-up of its operating entity, located in Dublin (Ireland), that will support several initiatives including an opportunity for non-dilutive investment as well as several possible strategic partnerships.

betterU had also decided to advance its India marketplace after observing a significant 1,272% increase in registrations and transactions over the same period last year. Nearly 55,000 new users and 12,000 new transactions enrolled in both free and paid courses. While the revenues were only a few thousand dollars, the length of time users have been spending on the marketplace has validated the growing level of interest. To capitalized on this growth trend, the Company has recently launched their new retooled India platform that aligns with their new SaaS model and includes a reduction of content offered, focused exclusively on skills development.

The several thousand courses and assessments being provided in India will now be hosted exclusively by betterU and to drive more awareness, the company is going to launch a marketing campaign promoting their new platform targeting its over 129,000 Facebook followers from India. The Company has also simplified the user experience by centralizing the back-end infrastructure for content integration, user management and now any transactions or updates required to be made, would be completed by betterU Canada and instantly be applied to all global platforms. This will enable seamless skills development solutions for millions of learners globally and support the scalability the Company has been working to establish.

betterU’s focus on its current clients has been to ensure the effective development of the platform, the ability to scale through automation and has renegotiated many content partner agreements for inclusion in the Company’s new SaaS model. In addition, betterU has developed a translation platform to support content delivery in localized languages for global employees and has launched its customized development services.

betterU is planning to support upwards of over 2,000 client employees within Ready-To-Go in the coming months and to support these growing opportunities, the Company has been planning the addition of a national sales team focused on North America. The Company is expecting to roll out sales team by the end of August 2020.

On July 20th, 2020, betterU received a grant from Industrial Research Assistance Program in the amount of $32,524. Funds have been allocated to support Canadian employees. On July 31, 2020, betterU secured more than $62,000 in extraordinary profit through the sale of certain claim rights the Company inherited from a predecessor entity, which is unrelated to the business activities of betterU.

“2020 has turned out to be a promising year so far with the growth of excitement from our current clients as we advance our core products and the multitude of opportunities that continue to presence themselves. Our team has and continues to work exceptionally hard to advance corporate and government opportunities. The world has been forced to change due to COVID-19 and with remote learning, betterU will continue to advance our solutions to help support as many governments, companies, employees and students get access to quality, affordable, skills development programs. More updates will follow shortly”, said Brad Loiselle, CEO of betterU.

About betterU Education Corp.

betterU is an education-to-employment technology company offering an end-to-end solution leveraging business intelligence to automate skilling, reskilling and upskilling for companies operating on domestic and global scales. The Company supports the industry by providing them with everything an organization needs to launch and manage proper skills development programs so that they can focus on what really matters, their people!

Most companies spent too much time trying to source, integrate, customize and deliver fragmented skills development programs across their organization, when they should be focused solely on supporting their people. betterU’s integrated platform brings together the right technology, growing content library, customization, language options and is the most efficient affordable solution on the market. We don’t sell content, we help build better people.

For more information, please visit https://corporate.betteru.ca/corporate-gov/

Contact:

Brad Loiselle, CEO
1-613-695-4100
[email protected]

betterU Education Corp.
Investor Relations
Email: [email protected]

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: betterU Education Corp.

Tags: , , , , ,
Posted in betterU Education Corp | Comments Off on betterU $BTRU.ca Provides Business Update $ARCL $CPLA $BPI $FC.ca

VIDEO: Loop Insights $MTRX.ca Pilot In 20 Locations Of Biggest CBD Retailer In America Could Lead To 550 Stores $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 5:08 PM on Thursday, August 20th, 2020
Loop Insights – Medium

Loop Insights (MTRX:TSXV) could very well be the best e-commerce technology company we’ve seen in the past 10 years.  We thought it when we saw it for the first time … and then the thinking really took hold when we showed Loop’s technology to retailer friends of ours, who jumped out of their phones.  

So what does Loop do? 

As their name suggests, they close the loop between brick and mortar locations and their e-commerce stores

But how do they do that?

Well, we know that all e-commerce sites have easy access to real-time insights, which leads to personal marketing.  That’s how:

  • Amazon recommends a product based on a real-time purchase you are making;
  • Spotify recommends music based on music you are listening to in real-time; 
  • NetFlix recommends other movies based on what you just watched.

What Loop is doing is creating that same experience for you in a physical retail location, which has NEVER been done.  Whether you are in a hotel, casino, store, or stadium, Loop’s disruptive capability creates a real-time increase in spend, loyalty, foot traffic and wallet share.   But don’t just take our word for it, here is what the largest brick & mortar CBD retailer in America had to say:  

“There’s no greater time to utilize top-tier artificial intelligence technology to gain an edge in this industry. Our customer base is huge, and it’s important to understand their needs and preferences to maximize basket size, loyalty and wallet share. We look forward to working with Loop and building unparalleled experiences for our customers.”

  If that wasn’t enough, here is what MTRX announced last month:  

Now you know why we’re calling Loop Insights the best e-commerce technology company we’ve seen in 10 years.  

Grab your favourite summer beverage, get comfortable and watch this powerful video with CEO, Rob Anson.    

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, Featured, Loop Insights Inc. | Comments Off on VIDEO: Loop Insights $MTRX.ca Pilot In 20 Locations Of Biggest CBD Retailer In America Could Lead To 550 Stores $QUIS.ca $MCLD.ca $NXO.ca

Innocan $INNO.ca to Distribute Its #CBD Line of Products in Italy and Switzerland $GWPH $CRDL.ca $PCLO.ca

Posted by AGORACOM-JC at 4:07 PM on Thursday, August 20th, 2020
Innocan-Blog
  • Entered into a distribution agreement with a Swiss CBD provider called Cloud 9 Switzerland LLC to sell the Company’s SHIR Beauty and Relief & Go product lines in Italy and Switzerland
  • Cloud 9 will distribute Innocan’s unique cosmetic CBD products in Italy and Switzerland on a nonexclusive basis

Herzliya, Israel and Calgary, Alberta–(August 20, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce that its wholly owned subsidiary, Innocan Pharma Ltd. (“Innocan Israel“) has entered into a distribution agreement (the “Agreement“) with a Swiss CBD provider called Cloud 9 Switzerland LLC (“Cloud 9“) to sell the Company’s SHIRTM Beauty and Relief & Go product lines in Italy and Switzerland.

Under the terms of the Agreement, Cloud 9 will distribute Innocan’s unique cosmetic CBD products in Italy and Switzerland on a nonexclusive basis. The Agreement defines the ordering and delivery mechanisms for the products and the marketing cooperation between the parties. The parties intend to carry out the Agreement immediately, following the completion of all registration and regulatory requirements in Italy and Switzerland.



Figure 1

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6922/62207_556f93134488c88c_002full.jpg

“In these extraordinary times, cannabis based pharma and cosmetic products respond to consumers’ desires for a more natural and healthy lifestyle. Innocan has a proven high-level expertise and shared vision making them an ideal partner for us to develop these new markets,” said Cloud 9’s Founder and Managing Director, Dr. Francis Scanlan.

Iris Bincovich, Innocan’s Founder and CEO, commented, “We are excited to have our products distributed in Switzerland and Italy. This is the second distribution agreement we have signed in Europe. I believe Cloud 9 will provide professional distribution of our SHIR and Relief & Go product lines.”

Additionally, on July 7, 2020, the Company has engaged AGORACOM for investor awareness, marketing and branding services (the “Services“) for a 12-month online marketing campaign to engage current shareholders and the broader investment community. As consideration for the Services, Innocan will pay to AGORACOM an aggregate of $75,000 (plus applicable taxes) by way of the issuance of common shares of the Company (the “Shares“), subject to regulatory and Canadian Securities Exchange approval. The Shares are payable in five equal installments during the period from August 2020 to July 2021, as further provided for in the online marketing agreement between the Company and AGORACOM. The number of Shares to be issued under each installment will be determined by using the closing price of the common shares of Innocan on the last trading day following each period during which the Services were provided.

AGORACOM will initiate Innocan’s “HUB” which may be found at: https://agoracom.com/ir/InnocanPharma

George Tsiolis, AGORACOM’s Founder, stated, “With the cannabis markets having consolidated over the past year due to failed business plans, investors are now demanding better companies with real businesses, products, and revenues that are supported by real growth plans. Innocan checks all the boxes, with commercialization of their consumer products now commencing, as well as, a pharmaceutical division that is developing the pharmaceutical guided missile to defeat coronavirus-infected lungs. It won’t take long for the community to realize Innocan will form part of the new leadership group of cannabis driven pharmaceutical companies. We’re proud to take the Innocan story to the world.”

About Cloud 9 Switzerland LLC

The Cloud 9 Group of private companies comprises the founding company Cloud 9 Switzerland LLC, and its subsidiaries in Jamaica and France. All three are active in the health and wellness sectors, developing, producing and commercialising pharmaceuticals and nutraceuticals based on medicinal and aromatic plants – notably hemp/cannabis sativa L. Since its founding in July 2017, the group has focused on developing and commercialising premium hemp and cannabis products, building a unique portfolio of food, beverages and cosmetics; selective third party brands; and prescription and over-the-counter (OTC) medicines.

About AGORACOM

Agoracom provides online marketing, broadcasting, conferencing and investor relations services to North American small and mid-cap public companies, with more than 300 companies served. AGORACOM states that it is the home of more than 7.7 million users who have visited its site 55.2 million times and read over 600 million pages of information over the last 10 years. AGORACOM further states that the average user visit of 8min 43sec is more than double that of global financial sites, which can be attributed to the implementation and enforcement of the strongest moderation rules in the industry.

About Innocan

The Company, through its wholly owned subsidiary, Innocan Pharma Ltd., is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD“). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. The Company plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Tags: , , , , , , ,
Posted in Featured, Innocan Pharma Corporation | Comments Off on Innocan $INNO.ca to Distribute Its #CBD Line of Products in Italy and Switzerland $GWPH $CRDL.ca $PCLO.ca

Datametrex $DM.ca Signs Another $250,000 Sales Contract With #LOTTE

Posted by AGORACOM-JC at 2:37 PM on Thursday, August 20th, 2020
  • Entered into additional agreement for providing IT solution and services totalling approximately $250,000 with two divisions of LOTTE companies, LOTTE Home Shopping and LOTTE Property and Development
  • Datametrex is continuously working with the various divisions of LOTTE and has demonstrated to be a quality, reliable, and trustworthy AI technology solutions vendor, providing critical optimizations for business structures
  • This relationship is demonstrating that there is an opportunity to grow Datametrex’s footprint within LOTTE’s distinct organizations

TORONTO, Aug. 20, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has entered into additional agreement for providing IT solution and services totalling approximately $250,000 with two divisions of LOTTE companies (“LOTTE”), LOTTE Home Shopping and LOTTE Property and Development.

LOTTE Home Shopping aims to provide a creative consumer experience by working with customers to build trust and satisfy their needs. It operates businesses in the areas of television shopping, Internet shopping malls, catalogues, and mobile shopping in South Korea and internationally, including locations in Japan, South Korea, China, Indonesia, and Vietnam.

LOTTE Property & Development operates as a high rise multi-purpose shopping mall and provides the LOTTE World Tower and the LOTTE World Mall with environmentally friendly urban green complex development, operations, and other related services.

Datametrex is continuously working with the various divisions of LOTTE and has demonstrated to be a quality, reliable, and trustworthy AI technology solutions vendor, providing critical optimizations for business structures.  This relationship is demonstrating that there is an opportunity to grow Datametrex’s footprint within LOTTE’s distinct organizations.

“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. We pride ourselves in providing tools that our clients can use to visualize their customers and stakeholders to make predictive analyses, mitigate risk, and improve their bottom line,” stated Marshall Gunter, CEO of Datametrex.

About LOTTE

LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions. LOTTE is engaged in diverse industries that include hotels, resorts, fast food, beverages, retail, financial services, heavy chemicals, electronics, IT, construction, publishing, confectionary products, and entertainment. Additional information on LOTTE is available at www.lotte.co.kr

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , , , ,
Posted in Datametrex AI Limited | Comments Off on Datametrex $DM.ca Signs Another $250,000 Sales Contract With #LOTTE

Datametrex $DM.ca Announces Purchase Orders and Completion of Delivery

Posted by AGORACOM-JC at 8:08 AM on Thursday, August 20th, 2020
  • Announced that it has received a second Purchase Order from Canadian Royalties Inc., a private mining company operating a copper and nickel mine in Nunavik, Quebec
  • This P.O. is for 2,000 tests with 1copy test kits, approximately $200,000 in sales, making the total sales to date approximately $400,000
  • Datametrex has completed delivery to another Canadian mining company for their South America mining site and has completed shipping 30,000 1copy test kits, 30,000 UTMs, a PCR machine, 30,000 RNA extraction kits and an RNA extraction machine
  • Approximate sales from this transaction is $850,000.The Company received its payment in full

TORONTO, Aug. 20, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received a second Purchase Order (“P.O.”) from Canadian Royalties Inc. (“CRI”), a private mining company operating a copper and nickel mine in Nunavik, Quebec. This P.O. is for 2,000 tests with 1copy test kits, approximately $200,000 in sales, making the total sales to date approximately $400,000.

Canadian Royalties is committed to occupational health and safety, and with the help of Datametrex, Canadian Royalties is endeavouring to allow its workforce to continue to operate with less risk. Canadian Royalties has over 1,000 employees at the Nunavik Nickel Project. On average, 400 people live and work on constant rotation at the Project, whether at the EXPO or Deception Bay camps, all on a fly-in / fly-out rotation.

Datametrex has completed delivery to another Canadian mining company for their South America mining site and has completed shipping 30,000 1copy test kits, 30,000 UTMs, a PCR machine, 30,000 RNA extraction kits and an RNA extraction machine. Approximate sales from this transaction is $850,000.The Company received its payment in full.

“We are thrilled to be able to support the operations of these mining companies as they endeavour to protect their employees and minimize the dangers, risks, and impacts that COVID-19 has brought,” stated Marshall Gunter, CEO of Datametrex.

About Canadian Royalties Inc.
Canadian Royalties Inc. (“CRI”) is a private mining company based in Montreal that operates a copper and nickel mine in Nunavik (province of Quebec), under the name Nunavik Nickel Project (“Project”). CRI is solely owned by their parent company in China, Jilin Jien Nickel Industry Co., Ltd. Canadian Royalties Inc. will engage the commitment and involvement of all of its employees and contractors to ensure that environmental, health and safety performance objectives are met. Additional information on Canadian Royalties is available at https://www.canadianroyalties.com/

About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Announces Purchase Orders and Completion of Delivery

« Older Entries
Newer Entries »